Insulin detemir causes increased symptom awareness during hypoglycaemia compared to human insulin

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2009-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1463-1326.2009.01085.xPMID 19650876
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin Detemir

  2012cited by this paper
• Different Brain Responses to Hypoglycemia Induced by Equipotent Doses of the Long-Acting Insulin Analog Detemir and Human Regular Insulin in Humans

  2008cited by this paper
• A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

  2007cited by this paper
• Albumin‐bound basal insulin analogues (insulin detemir and NN344): comparable time‐action profiles but less variability than insulin glargine in type 2 diabetes

  2007cited by this paper
• Cerebrocortical Beta Activity in Overweight Humans Responds to Insulin Detemir

  2007cited by this paper
• The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: A magnetoencephalographic study

  2006cited by this paper
• Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes

  2006cited by this paper
• Tissue selectivity of insulin detemir action in vivo

  2006cited by this paper
• Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia.

  2005cited by this paper
• The Mechanism of Protraction of Insulin Detemir, a Long-Acting, Acylated Analog of Human Insulin

  2004cited by this paper
• Engineering predictability and protraction in a basal insulin analogue: the pharmacology of insulin detemir

  2004cited by this paper
• Transcortical direct current potential shift reflects immediate signaling of systemic insulin to the human brain.

  2004cited by this paper
• Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart.

  2003cited by this paper
• Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?

  2002cited by this paper
• Avoidance of Hypoglycemia Restores Hypoglycemia Awareness by Increasing -Adrenergic Sensitivity in Type 1 Diabetes

  2001cited by this paper
• Improving Influence of Insulin on Cognitive Functions in Humans

  2001cited by this paper
• Effects of insulin per se on neuroendocrine and metabolic counter-regulatory responses to hypoglycaemia.

  2000cited by this paper
• Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine

  2000cited by this paper
• Symptomatic and counterregulatory hormonal responses to acute hypoglycaemia induced by insulin aspart and soluble human insulin in Type 1 diabetes

  2000cited by this paper
• Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use.

  2000cited by this paper
• Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin

  1997cited by this paper
• Counterregulatory Hormone Responses and Symptoms During Hypoglycaemia Induced by Porcine, Human Regular Insulin, and Lys(B28), Pro(B29) Human Insulin Analogue (Insulin Lispro) in Healthy Male Volunteers

  1997cited by this paper
• Effect of fatty acids and selected drugs on the albumin binding of a long-acting, acylated insulin analogue.

  1997cited by this paper
• Albumin binding and time action of acylated insulins in various species.

  1996cited by this paper
• Insulin-associated modulation of neuroendocrine counterregulation, hypoglycemia perception, and cerebral function in insulin-dependent diabetes mellitus: evidence for an intrinsic effect of insulin on the central nervous system.

  1996cited by this paper
• Mechanism of awareness of hypoglycemia. Perception of neurogenic (predominantly cholinergic) rather than neuroglycopenic symptoms.

  1993cited by this paper
• Mechanism of Awareness of Hypoglycemia: Perception of Neurogenic (Predominantly Cholinergic) Rather Than Neuroglycopenic Symptoms

  1993cited by this paper
• Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans.

  1991cited by this paper
• Importance of Insulin in Subjective, Cognitive, and Hormonal Responses to Hypoglycemia in Patients With IDDM

  1991cited by this paper
• Symptoms of Acute Insulin-Induced Hypoglycemia in Humans With and Without IDDM: Factor-Analysis Approach

  1991cited by this paper

• Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial

  2023cites this paper
• The Effects of Self-Control on Glucose Utilization in a Hyperinsulinemic Euglycemic Glucose Clamp

  2019cites this paper
• A Systematic Review of Neuroprotective Strategies in the Management of Hypoglycemia

  2019influential citation
• Sustained Treatment with Insulin Detemir in Mice Alters Brain Activity and Locomotion

  2016cites this paper
• Возможности применения инсулина детемир при лечении сахарного диабета у беременных: доказанные преимущества и перспективы использования

  2016cites this paper
• Long-acting insulin analog detemir displays reduced effects on adipocyte differentiation of human subcutaneous and visceral adipose stem cells.

  2016cites this paper
• Detemir potential applications in the treatment of diabetes during pregnancy: proven benefits and perspectives

  2016cites this paper
• Insulin degludec is not associated with a delayed or diminished response to hypoglycaemia compared with insulin glargine in type 1 diabetes: a double-blind randomised crossover study

  2013cites this paper
• Detemir (Levemir): modern paradigms of insulin therapy

  2013cites this paper
• Metabolic Syndrome and Obesity : Targets and Therapy Insulin detemir for the treatment of obese patients with type 2 diabetes

  2012cites this paper
• Brain meets body: the blood-brain barrier as an endocrine interface.

  2012cites this paper
• Insulin Detemir

  2012cites this paper
• Insulin detemir for the treatment of obese patients with type 2 diabetes

  2012cites this paper
• An update on the treatment of type 1 and type 2 diabetes mellitus: focus on insulin detemir, a long-acting human insulin analog

  2010cites this paper
• Euglycemic Infusion of Insulin Detemir Compared With Human Insulin Appears to Increase Direct Current Brain Potential Response and Reduces Food Intake While Inducing Similar Systemic Effects

  2010influential citation
• Brain Insulin Action Regulates Hypothalamic Glucose Sensing and the Counterregulatory Response to Hypoglycemia

  2010cites this paper
• Insulin detemir is not transported across the blood-brain barrier.

  2010cites this paper
• Impaired awareness of hypoglycaemia: a review.

  2010cites this paper
• Current literature in diabetes

  2010cites this paper
• Vascular Health and Risk Management Dovepress an Update on the Treatment of Type 1 and Type 2 Diabetes Mellitus: Focus on Insulin Detemir, a Long-acting Human Insulin Analog

  year unknowncites this paper